XML 20 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue
 3 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The Company recorded the following revenues for the three months ended March 31, 2025 and 2024 (in thousands):
Three Months Ended March 31,
20252024
ORLADEYO:
U.S.$120,159 $79,966 
Outside of U.S.14,084 8,901 
Total ORLADEYO134,243 88,867 
Other revenues11,291 3,894 
Total revenues$145,534 $92,761 
ORLADEYO revenues represent total revenues from product sales, collaborative revenues, and royalties. Other revenues primarily relate to the Company’s product sales and royalties for peramivir.
No individual country outside of the U.S. exceeded 10% of total revenues for the three months ended March 31, 2025 and 2024.